CD Private Equity Fund III
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CD3.AX research report →
Price Chart
About the company
CD Private Equity Fund III allocates its capital to boutique and focused private equity funds. These funds are designed to acquire and cultivate lower middle-market operating companies specifically within the American market.
- IPO
- 2016
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on CD3.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $59.06M
- P/E
- -6.55
- PEG
- 0.04
- P/S
- -96.42
- P/B
- 0.51
- EV/EBITDA
- -5.23
- Div Yield
- 31.71%
- Gross Margin
- 185.31%
- Op Margin
- 1586.34%
- Net Margin
- 1471.69%
- ROE
- -7.49%
- ROIC
- -7.56%
Latest fiscal year · YoY change
- Revenue
- $-612,539-257.9%
- Gross Profit
- $-1,135,098-563.2%
- Op Income
- $-9,716,932
- Net Income
- $-9,014,646-148.6%
- EPS
- $-0.13-150.0%
- OCF Growth
- -14.6%
- FCF Growth
- -14.6%
- 52W High
- $1.26
- 52W Low
- $0.76
- 50D MA
- $0.88
- 200D MA
- $0.97
- Beta
- -0.24
- RSI (14)
- 43
- Avg Volume
- 48.34K
No earnings-call transcripts are available for CD3.AX yet.
- Free Float
- 90.1%
- Shares Outstanding
- 72.03M
- Float Shares
- 64.89M
Our CD3.AX coverage
Recent articles, reports, and earnings notes.
No research on CD3.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CD3.AX report →